Bangalore, 13th November,2025: The India Chamber of Business & Commerce put out the country’s first white paper on “Quantum Ayurveda (QA)” this week. This was a big step forward for India’s health and wellness business. At the same time, Greenspace Herbs started selling quantum-engineered Ayurvedic ingredients in the US and India. They have ambitious plans for global growth.
The white paper, which was put together by the Rural Economic Forum, says that Quantum Ayurveda is a discipline that combines resonance science, spectroscopy, and AI with traditional Ayurvedic principles. It has contributions from India’s research community, such as a foreword by the leaders of the India Chamber of Commerce and an ICMR scientist’s point of view.
From Milligrams to Megahertz
The paper argues for a change “from dosage to signal,” showing how botanicals can be mapped for spectral signatures, loaded with optimised resonance, stabilised in the plant lattice, and checked through analytics and clinical research. The authors talk about how Ayurveda can be “moved from milligrams to megahertz” in four steps: mapping, resonance loading, stabilisation, and validation.
The chamber says that the global botanicals market will be worth more than $400 billion by 2030 and tells India to stop exporting raw herbs. India grows almost a quarter of the world’s herbs but only gets less than 5% of value-added trade. The white paper says that products made with resonance engineering could increase export revenues by three to five times while also improving nutrition security and rural incomes.
The launch of Greenspace Herbs’ QA Portfolio
Greenspace Herbs, which calls itself “the quantum Ayurveda company,” spent 3.5 years doing research and development on quantum physics applications with advanced AI like NutrifyGenie AI. Greenspace Herbs showed off what it calls the world’s first Quantum Ayurveda portfolio at SupplySide Global in October 2025 in Las Vegas.
There are now five products available: three single-ingredient EASI (Energised Active Supplement Ingredients) lines: Curcumin QA, Berberine QA, and Ashwagandha QA—and two EASI Polyblends—NerviQA for cognitive support and FemHealQA for support during peri-menopause. Greenspace Herbs will release five more products in 2026.
EASI singles are “signature energy-locked” versions of popular actives. When you eat them, they release resonance, which lowers oxidative stress and improves the performance of the ingredients. This means you can take lower doses, feel better faster, and tolerate them better. The Polyblend track uses synergy frequency signatures to combine secondary botanicals with a “hero” ingredient that has a lot of resonance.
Infrastructure and Standards
The white paper suggests infrastructure that regulators and investors can use to judge national spectral libraries of Ayurvedic plants, AI platforms for clinical evidence, digital-twin models for predicting efficacy, and blockchain-plus-IoT traceability from farm to formula. We want clear, repeatable standards that are in line with the WHO, US FDA, EMA, and ASEAN frameworks.
The document talks about scientists who are linked to ICMR and lists the clinical pathways that are being studied, such as bioavailability, oxidative stress markers, immune modulation, and how resonance-enhanced extracts compare to regular extracts in terms of effectiveness.
Important Voices
Nitin Pangotra, President and CEO of the India Chamber of Business and Commerce, said, “This is more than an innovation; it is a paradigm shift. He described Quantum Ayurveda as a bridge that “connects farmers to laboratories” and changes India’s role from heritage custodian to standard-setter.”
Dr Ravinder Singh, Senior Scientist at ICMR HQ, wrote: “Quantum Ayurveda promises not only to improve global health outcomes but also to revitalise India’s rural and MSME sectors. He stressed the need for alignment with international regulators while making sure that farmers are included and that benefits are shared fairly.”
“Quantum Ayurveda lets us engineer the ‘signal’ inside nature’s most trusted ingredients,” said Shafiulla Nuruddin Hirehal, Director of Greenspace Herbs. “Formulators in the US and India can make products that are cleaner, faster, and easier on the body with QA-inside.”
The Triple Dividend
The paper talks about a “triple dividend” for investors: lower chronic disease rates through preventive, evidence-based botanicals; higher export value and jobs through resonance-engineered IP; and rural empowerment through traceable supply chains. The chamber wants to push this agenda forward in trade talks and standards groups until 2025-26.
What Comes Next
All five QA products can be bought by US brands and Indian manufacturers. The white paper says that consistent analytical signatures, human data, and label transparency are important for global acceptance as the category matures.
The 2025 Las Vegas debut is a big deal for the whole world. If Greenspace Herbs’ QA-inside model and the chamber’s standards agenda work, India could export not just herbs but also a whole stack of protocols, spectral references, and clinical playbooks. This would give India the defensible, scalable know-how it needs to get a big share of the $400 billion botanical economy.
